Loading…

Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead

The relationship between healthcare professionals and the pharmaceutical industry is under intense scrutiny. Accusations of corrupt practices have been levelled at the industry by both the professional and the lay press. The environment is changing, with rising expectations of transparency and ethic...

Full description

Saved in:
Bibliographic Details
Published in:Paediatric respiratory reviews 2006-03, Vol.7 (1), p.60-66
Main Authors: Leather, David A., Davis, Sarah C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c305t-c40d16063f127d9ae19add187c98ed40d2037f19b52f9e13e4fa13fe676431873
container_end_page 66
container_issue 1
container_start_page 60
container_title Paediatric respiratory reviews
container_volume 7
creator Leather, David A.
Davis, Sarah C.
description The relationship between healthcare professionals and the pharmaceutical industry is under intense scrutiny. Accusations of corrupt practices have been levelled at the industry by both the professional and the lay press. The environment is changing, with rising expectations of transparency and ethical standards. In addition, society is becoming increasingly risk averse. There have been examples of poor practice by industry in the past, and industry is learning from these. Equally, there are many examples of excellent practice where industry has worked effectively and ethically with clinicians. The goal of industry is to bring new medicines to benefit patients and shareholders. Commercial success is dependent upon putting the patient at the centre of activity. It also allows re-investment into research and development. This allies industry and healthcare professionals with a common and key ethical arbitrator – the patient. Industry is changing as an acknowledgement of the need to adapt to the culture change demanded by society. Self regulation is increasingly active and transparent; guidelines, laws and internal/external regulators exist to examine industry. However, for the changes in regulations, behaviour and practices to be fully effective, there is a need for dialogue between industry and healthcare professionals. Commitment is needed from both sides to work together to manage the relationship.
doi_str_mv 10.1016/j.prrv.2005.11.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67658118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S152605420500117X</els_id><sourcerecordid>67658118</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-c40d16063f127d9ae19add187c98ed40d2037f19b52f9e13e4fa13fe676431873</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EolD4ARYoK3YJHjtPxAZVvKRKsIC15dpj4ipNgp1U6t_j0qrsWHmsOffKPoRcAU2AQn67THrn1gmjNEsAEkrZETmDjOUxzTJ6fJhTNiHn3i8pBcgpnJIJ5GnBS6jOiHiXqK0cnFVWtj6SrY6GGqO-lm4lFY6DVbKJbKtHP7jNXQAOl6hH53tUg11j1JnfnKpl02D7haGqRqkvyImRjcfL_Tkln0-PH7OXeP72_Dp7mMeK02yIVUp1eFvODbBCVxKhklpDWaiqRB2WjPLCQLXImKkQOKZGAjeYF3nKA8an5GbX27vue0Q_iJX1CptGttiNXgQwKwHKALIdqFznvUMjemdX0m0EULHVKpZiq1VstQoAEbSG0PW-fVysUP9F9h4DcL8DMPxxbdEJryy2Krh1QZDQnf2v_wdpLIpK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67658118</pqid></control><display><type>article</type><title>Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead</title><source>ScienceDirect Journals</source><creator>Leather, David A. ; Davis, Sarah C.</creator><creatorcontrib>Leather, David A. ; Davis, Sarah C.</creatorcontrib><description>The relationship between healthcare professionals and the pharmaceutical industry is under intense scrutiny. Accusations of corrupt practices have been levelled at the industry by both the professional and the lay press. The environment is changing, with rising expectations of transparency and ethical standards. In addition, society is becoming increasingly risk averse. There have been examples of poor practice by industry in the past, and industry is learning from these. Equally, there are many examples of excellent practice where industry has worked effectively and ethically with clinicians. The goal of industry is to bring new medicines to benefit patients and shareholders. Commercial success is dependent upon putting the patient at the centre of activity. It also allows re-investment into research and development. This allies industry and healthcare professionals with a common and key ethical arbitrator – the patient. Industry is changing as an acknowledgement of the need to adapt to the culture change demanded by society. Self regulation is increasingly active and transparent; guidelines, laws and internal/external regulators exist to examine industry. However, for the changes in regulations, behaviour and practices to be fully effective, there is a need for dialogue between industry and healthcare professionals. Commitment is needed from both sides to work together to manage the relationship.</description><identifier>ISSN: 1526-0542</identifier><identifier>EISSN: 1526-0550</identifier><identifier>DOI: 10.1016/j.prrv.2005.11.002</identifier><identifier>PMID: 16473819</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>commerce ; conflict of interest ; drug industry ; Drug Industry - ethics ; Drug Industry - legislation &amp; jurisprudence ; ethics ; Ethics, Medical ; Ethics, Professional ; Humans ; Interprofessional Relations ; paediatrics ; Pediatrics - ethics ; Professional Misconduct ; Risk Assessment ; Social Control, Formal</subject><ispartof>Paediatric respiratory reviews, 2006-03, Vol.7 (1), p.60-66</ispartof><rights>2005 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c305t-c40d16063f127d9ae19add187c98ed40d2037f19b52f9e13e4fa13fe676431873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16473819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leather, David A.</creatorcontrib><creatorcontrib>Davis, Sarah C.</creatorcontrib><title>Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead</title><title>Paediatric respiratory reviews</title><addtitle>Paediatr Respir Rev</addtitle><description>The relationship between healthcare professionals and the pharmaceutical industry is under intense scrutiny. Accusations of corrupt practices have been levelled at the industry by both the professional and the lay press. The environment is changing, with rising expectations of transparency and ethical standards. In addition, society is becoming increasingly risk averse. There have been examples of poor practice by industry in the past, and industry is learning from these. Equally, there are many examples of excellent practice where industry has worked effectively and ethically with clinicians. The goal of industry is to bring new medicines to benefit patients and shareholders. Commercial success is dependent upon putting the patient at the centre of activity. It also allows re-investment into research and development. This allies industry and healthcare professionals with a common and key ethical arbitrator – the patient. Industry is changing as an acknowledgement of the need to adapt to the culture change demanded by society. Self regulation is increasingly active and transparent; guidelines, laws and internal/external regulators exist to examine industry. However, for the changes in regulations, behaviour and practices to be fully effective, there is a need for dialogue between industry and healthcare professionals. Commitment is needed from both sides to work together to manage the relationship.</description><subject>commerce</subject><subject>conflict of interest</subject><subject>drug industry</subject><subject>Drug Industry - ethics</subject><subject>Drug Industry - legislation &amp; jurisprudence</subject><subject>ethics</subject><subject>Ethics, Medical</subject><subject>Ethics, Professional</subject><subject>Humans</subject><subject>Interprofessional Relations</subject><subject>paediatrics</subject><subject>Pediatrics - ethics</subject><subject>Professional Misconduct</subject><subject>Risk Assessment</subject><subject>Social Control, Formal</subject><issn>1526-0542</issn><issn>1526-0550</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EolD4ARYoK3YJHjtPxAZVvKRKsIC15dpj4ipNgp1U6t_j0qrsWHmsOffKPoRcAU2AQn67THrn1gmjNEsAEkrZETmDjOUxzTJ6fJhTNiHn3i8pBcgpnJIJ5GnBS6jOiHiXqK0cnFVWtj6SrY6GGqO-lm4lFY6DVbKJbKtHP7jNXQAOl6hH53tUg11j1JnfnKpl02D7haGqRqkvyImRjcfL_Tkln0-PH7OXeP72_Dp7mMeK02yIVUp1eFvODbBCVxKhklpDWaiqRB2WjPLCQLXImKkQOKZGAjeYF3nKA8an5GbX27vue0Q_iJX1CptGttiNXgQwKwHKALIdqFznvUMjemdX0m0EULHVKpZiq1VstQoAEbSG0PW-fVysUP9F9h4DcL8DMPxxbdEJryy2Krh1QZDQnf2v_wdpLIpK</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Leather, David A.</creator><creator>Davis, Sarah C.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead</title><author>Leather, David A. ; Davis, Sarah C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-c40d16063f127d9ae19add187c98ed40d2037f19b52f9e13e4fa13fe676431873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>commerce</topic><topic>conflict of interest</topic><topic>drug industry</topic><topic>Drug Industry - ethics</topic><topic>Drug Industry - legislation &amp; jurisprudence</topic><topic>ethics</topic><topic>Ethics, Medical</topic><topic>Ethics, Professional</topic><topic>Humans</topic><topic>Interprofessional Relations</topic><topic>paediatrics</topic><topic>Pediatrics - ethics</topic><topic>Professional Misconduct</topic><topic>Risk Assessment</topic><topic>Social Control, Formal</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leather, David A.</creatorcontrib><creatorcontrib>Davis, Sarah C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Paediatric respiratory reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leather, David A.</au><au>Davis, Sarah C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead</atitle><jtitle>Paediatric respiratory reviews</jtitle><addtitle>Paediatr Respir Rev</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>7</volume><issue>1</issue><spage>60</spage><epage>66</epage><pages>60-66</pages><issn>1526-0542</issn><eissn>1526-0550</eissn><abstract>The relationship between healthcare professionals and the pharmaceutical industry is under intense scrutiny. Accusations of corrupt practices have been levelled at the industry by both the professional and the lay press. The environment is changing, with rising expectations of transparency and ethical standards. In addition, society is becoming increasingly risk averse. There have been examples of poor practice by industry in the past, and industry is learning from these. Equally, there are many examples of excellent practice where industry has worked effectively and ethically with clinicians. The goal of industry is to bring new medicines to benefit patients and shareholders. Commercial success is dependent upon putting the patient at the centre of activity. It also allows re-investment into research and development. This allies industry and healthcare professionals with a common and key ethical arbitrator – the patient. Industry is changing as an acknowledgement of the need to adapt to the culture change demanded by society. Self regulation is increasingly active and transparent; guidelines, laws and internal/external regulators exist to examine industry. However, for the changes in regulations, behaviour and practices to be fully effective, there is a need for dialogue between industry and healthcare professionals. Commitment is needed from both sides to work together to manage the relationship.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>16473819</pmid><doi>10.1016/j.prrv.2005.11.002</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1526-0542
ispartof Paediatric respiratory reviews, 2006-03, Vol.7 (1), p.60-66
issn 1526-0542
1526-0550
language eng
recordid cdi_proquest_miscellaneous_67658118
source ScienceDirect Journals
subjects commerce
conflict of interest
drug industry
Drug Industry - ethics
Drug Industry - legislation & jurisprudence
ethics
Ethics, Medical
Ethics, Professional
Humans
Interprofessional Relations
paediatrics
Pediatrics - ethics
Professional Misconduct
Risk Assessment
Social Control, Formal
title Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A04%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Paediatricians%20and%20the%20pharmaceutical%20industry:%20an%20industry%20perspective%20of%20the%20challenges%20ahead&rft.jtitle=Paediatric%20respiratory%20reviews&rft.au=Leather,%20David%20A.&rft.date=2006-03-01&rft.volume=7&rft.issue=1&rft.spage=60&rft.epage=66&rft.pages=60-66&rft.issn=1526-0542&rft.eissn=1526-0550&rft_id=info:doi/10.1016/j.prrv.2005.11.002&rft_dat=%3Cproquest_cross%3E67658118%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c305t-c40d16063f127d9ae19add187c98ed40d2037f19b52f9e13e4fa13fe676431873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67658118&rft_id=info:pmid/16473819&rfr_iscdi=true